Thursday, June 29, 2017
Clarity Benefit Solutions Lists Top Five Tools for Benefit Brokers
NEW YORK, June 29, 2017 /PRNewswire-iReach/ -- Online benefits administration and Dependent Care Flexible Spending Account provider, Clarity Benefit Solutions, shares the top five tools for benefit brokers.
Golf is Not a Passive Course: Physician Partners of America Calls for Golfers to Take Better Care While Hitting the Links
TAMPA, Fla., June 29, 2017 /PRNewswire/ -- Recent research by the American College of Sports Medicine suggests that recreational golfers are more vulnerable to long-term injury risk from the sport than many may think. The weekend golfer tries to use golf as a relaxation tool; but, in many cases, long-term injuries can affect .....
President Trump Challenged by Immunologist J. Bart Classen, MD of Classen Immunotherapies to Stop Dangerous Vaccine Policies
MANCHESTER, Md., June 29, 2017 /PRNewswire-USNewswire/ -- J. Bart Classen, MD  ( of Classen Immunotherapies has written the following letter on immunization policy to President Trump, that echoes Classen's.....

BeiGene Presents Preliminary Phase 1 Data on BGB-A317 in Patients with Hepatocellular Carcinoma at the ESMO 19th World Congress on Gastrointestinal Cancer

SciBase Receives US Approval for Nevisense
STOCKHOLM, June 29, 2017 /PRNewswire/ -- SciBase today announces that the US Food and Drug Administration (FDA) has approved the Scibase Pre-Market Approval (PMA) for its product Nevisense. Nevisense is SciBase's device for the early detection of malignant melanoma. With the approval, SciBa.....
ARMO BioSciences Presents Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer at ESMO World Congress on Gastrointestinal Cancer 2017
REDWOOD CITY, Calif., June 29, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at the ESMO 19th World Congress on Gastrointestinal Cancer, taking place <.....
Gabriel Health Announces Pilot to Combat Social Isolation
MELBOURNE, Australia, June 29, 2017 /PRNewswire/ -- Thousands of seniors are set to benefit from a large-scale pilot in Victoria to turn around the trend of social isolation, a silent but widespread and growing issue among older Australians.


  • Fitness App Market 29.45% CAGR by 2021 Says a New Research Report at
  • Home Healthcare Market Size Expected to Reach $391.41 Bn by 2021: Zion Market Research
  • Knee Implants Market Is Expected To Reach USD 13.5 Bn By 2025, Credence Research
  • C-TAC Launches Campaign to Transform Advanced Care
  • Facial Injectables Market Is Expected To Witness Growth Swiftly, Owing To Advancements In Facial Rejuvenation Procedures & Importance Of Medical Aesthetics Till 2025: Grand View Research, Inc

  • Novartis receives EU approval for first-line use of ZykadiaŽ in ALK-positive advanced non-small cell lung cancer (NSCLC)
  • Pharmaleads Reports Positive Phase I SAD Data with its Dual ENKephalinase Inhibitor (DENKI) PL265 for the Treatment of Neuropathic Pain
  • Low Uptake of Cancer Preventing Human Papillomavirus Vaccine Linked to Lasting Injection Fear Formed in Preschool
  • Community Health Accreditation Partner (CHAP) Announces President and CEO Departure
  • Polymedco, Inc. Acquires U.S. Distribution Rights to the PATHFAST Product Line

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines